Skip to main content
Top
Published in:

16-01-2024 | Review

Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis

Authors: Ye Zang, Yue Qiu, Yimeng Sun, Yu Fan

Published in: Quality of Life Research | Issue 6/2024

Login to get access

Abstract

Purpose

A consensus has not been reached on the value of quality of life (QoL) as a prognostic factor for survival in gastrointestinal cancer. This meta-analysis aimed to investigate the association between functioning scales of the EORTC QoL Questionnaire Core 30 (QLQ-C30) and the overall survival (OS) in patients with gastrointestinal cancer.

Methods

A systematic literature search was conducted in PubMed, Web of Science, and Embase databases, until February 7, 2023. The studies included were those that investigated the association between baseline QoL measured by the functioning scales of EORTC QLQ-C30 and OS in patients with gastrointestinal cancer. The prognostic capacity of QoL was calculated by pooling the adjusted hazard ratios (HR) with 95% confidence intervals (CI).

Results

Twenty-four studies' analyses reported by 22 eligible articles involving 11,609 patients were included. When compared with good parameters of QoL, poor global QoL (HR 1.81; 95% CI 1.53–2.13), physical functioning (HR 1.51; 95% CI 1.31–1.74), social functioning (HR 1.67; 95% CI 1.30–2.15), and role functioning scale (HR 1.42; 95% CI 1.20–1.29) were significantly associated with decreased OS. For each 10-point increase in QLQ-C30 parameters, the pooled HR of OS was 0.87 (95% CI 0.83–0.92) for global QoL, 0.87 (95% CI 0.83–0.92) for physical functioning, and 0.93 (95% CI 0.88–0.97) for role functioning. However, each 10-point increase in social, emotional, or cognitive functioning scale did not significantly predict OS.

Conclusions

Baseline health-related QoL defined by the physical functioning or global QoL scale of EORTC QLQ-C30 significantly predicts OS in patients with gastrointestinal cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kuntz, S., Krieghoff-Henning, E., Kather, J. N., Jutzi, T., Hohn, J., Kiehl, L., Hekler, A., Alwers, E., von Kalle, C., Frohling, S., Utikal, J. S., Brenner, H., Hoffmeister, M., & Brinker, T. J. (2021). Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review. European Journal of Cancer, 155, 200–215.PubMedCrossRef Kuntz, S., Krieghoff-Henning, E., Kather, J. N., Jutzi, T., Hohn, J., Kiehl, L., Hekler, A., Alwers, E., von Kalle, C., Frohling, S., Utikal, J. S., Brenner, H., Hoffmeister, M., & Brinker, T. J. (2021). Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review. European Journal of Cancer, 155, 200–215.PubMedCrossRef
2.
go back to reference Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020). Global burden of 5 major types of gastrointestinal cancer. Gastroenterology, 159(1), 335-349.e15.PubMedCrossRef Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020). Global burden of 5 major types of gastrointestinal cancer. Gastroenterology, 159(1), 335-349.e15.PubMedCrossRef
3.
go back to reference Lu, L., Mullins, C. S., Schafmayer, C., Zeissig, S., & Linnebacher, M. (2021). A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Communications, 41(11), 1137–1151.PubMedPubMedCentralCrossRef Lu, L., Mullins, C. S., Schafmayer, C., Zeissig, S., & Linnebacher, M. (2021). A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Communications, 41(11), 1137–1151.PubMedPubMedCentralCrossRef
4.
go back to reference Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48.PubMed Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48.PubMed
5.
go back to reference Lutz, A. T., Griza, A., Machado, G. M., Loose, U., Dahmer, A., & Herbert, J. S. (2022). Patient reported outcomes in the daily practice in clinical oncology: A systematic review. Critical Reviews in Oncology Hematology, 173, 103658.PubMedCrossRef Lutz, A. T., Griza, A., Machado, G. M., Loose, U., Dahmer, A., & Herbert, J. S. (2022). Patient reported outcomes in the daily practice in clinical oncology: A systematic review. Critical Reviews in Oncology Hematology, 173, 103658.PubMedCrossRef
6.
go back to reference Ahn, S., Jung, H., Kim, S., Shin, S. J., Park, C. G., & Chu, S. H. (2017). Quality of life among Korean gastrointestinal cancer survivors. European Journal of Oncology Nursing, 30, 15–21.PubMedCrossRef Ahn, S., Jung, H., Kim, S., Shin, S. J., Park, C. G., & Chu, S. H. (2017). Quality of life among Korean gastrointestinal cancer survivors. European Journal of Oncology Nursing, 30, 15–21.PubMedCrossRef
7.
go back to reference Kaplan, R. M., & Hays, R. D. (2022). Health-related quality of life measurement in public health. Annual Review of Public Health, 43, 355–373.PubMedCrossRef Kaplan, R. M., & Hays, R. D. (2022). Health-related quality of life measurement in public health. Annual Review of Public Health, 43, 355–373.PubMedCrossRef
8.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.PubMedCrossRef
9.
go back to reference Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102.PubMedPubMedCentralCrossRef Montazeri, A. (2009). Quality of life data as prognostic indicators of survival in cancer patients: An overview of the literature from 1982 to 2008. Health and Quality of Life Outcomes, 7, 102.PubMedPubMedCentralCrossRef
10.
go back to reference Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38(10), 1351–1357.PubMedCrossRef Maisey, N. R., Norman, A., Watson, M., Allen, M. J., Hill, M. E., & Cunningham, D. (2002). Baseline quality of life predicts survival in patients with advanced colorectal cancer. European Journal of Cancer, 38(10), 1351–1357.PubMedCrossRef
11.
go back to reference Efficace, F., Bottomley, A., Coens, C., Van Steen, K., Conroy, T., Schoffski, P., Schmoll, H., Van Cutsem, E., & Kohne, C. H. (2006). Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? European Journal of Cancer, 42(1), 42–49.PubMedCrossRef Efficace, F., Bottomley, A., Coens, C., Van Steen, K., Conroy, T., Schoffski, P., Schmoll, H., Van Cutsem, E., & Kohne, C. H. (2006). Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? European Journal of Cancer, 42(1), 42–49.PubMedCrossRef
12.
go back to reference Comella, P., Casaretti, R., Manzo, R., Sandomenico, C., Licenziato, M., Avallone, A., Franco, L., Southern Italy Cooperative Oncology Group, I. (2010). Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet. Acta Oncologica, 49(1), 50–56.PubMedCrossRef Comella, P., Casaretti, R., Manzo, R., Sandomenico, C., Licenziato, M., Avallone, A., Franco, L., Southern Italy Cooperative Oncology Group, I. (2010). Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet. Acta Oncologica, 49(1), 50–56.PubMedCrossRef
13.
go back to reference Braun, D. P., Gupta, D., Grutsch, J. F., & Staren, E. D. (2011). Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health and Quality of Life Outcomes, 9, 62.PubMedPubMedCentralCrossRef Braun, D. P., Gupta, D., Grutsch, J. F., & Staren, E. D. (2011). Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health and Quality of Life Outcomes, 9, 62.PubMedPubMedCentralCrossRef
14.
go back to reference Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A., Ringash, J., Gotay, C., Bjordal, K., Greimel, E., Reeve, B. B., Maringwa, J., Ediebah, D. E., Zikos, E., King, M. T., Osoba, D., Taphoorn, M. J., Flechtner, H., Schmucker-Von Koch, J., Weis, J., Bottomley, A., Patient Reported, O., Behavioral, E., the European Organization for, R., & Treatment of Cancer Clinical, G. (2014). A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer, 120(2), 302–311.PubMedCrossRef Quinten, C., Martinelli, F., Coens, C., Sprangers, M. A., Ringash, J., Gotay, C., Bjordal, K., Greimel, E., Reeve, B. B., Maringwa, J., Ediebah, D. E., Zikos, E., King, M. T., Osoba, D., Taphoorn, M. J., Flechtner, H., Schmucker-Von Koch, J., Weis, J., Bottomley, A., Patient Reported, O., Behavioral, E., the European Organization for, R., & Treatment of Cancer Clinical, G. (2014). A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer, 120(2), 302–311.PubMedCrossRef
15.
go back to reference Blazeby, J. M., Brookes, S. T., & Alderson, D. (2001). The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut, 49(2), 227–230.PubMedPubMedCentralCrossRef Blazeby, J. M., Brookes, S. T., & Alderson, D. (2001). The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut, 49(2), 227–230.PubMedPubMedCentralCrossRef
16.
go back to reference Fang, F. M., Tsai, W. L., Chiu, H. C., Kuo, W. R., & Hsiung, C. Y. (2004). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation Oncology Biology Physics, 58(5), 1394–1404.PubMedCrossRef Fang, F. M., Tsai, W. L., Chiu, H. C., Kuo, W. R., & Hsiung, C. Y. (2004). Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. International Journal of Radiation Oncology Biology Physics, 58(5), 1394–1404.PubMedCrossRef
17.
go back to reference Chau, I., Norman, A. R., Cunningham, D., Waters, J. S., Oates, J., & Ross, P. J. (2004). Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer–pooled analysis from three multicenter, randomized, controlled trials using individual patient data. Journal of Clinical Oncology, 22(12), 2395–2403.PubMedCrossRef Chau, I., Norman, A. R., Cunningham, D., Waters, J. S., Oates, J., & Ross, P. J. (2004). Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer–pooled analysis from three multicenter, randomized, controlled trials using individual patient data. Journal of Clinical Oncology, 22(12), 2395–2403.PubMedCrossRef
18.
go back to reference Blazeby, J. M., Metcalfe, C., Nicklin, J., Barham, C. P., Donovan, J., & Alderson, D. (2005). Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. British Journal of Surgery, 92(12), 1502–1507.PubMedCrossRef Blazeby, J. M., Metcalfe, C., Nicklin, J., Barham, C. P., Donovan, J., & Alderson, D. (2005). Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. British Journal of Surgery, 92(12), 1502–1507.PubMedCrossRef
19.
go back to reference Park, S. H., Cho, M. S., Kim, Y. S., Hong, J., Nam, E., Park, J., Cho, E. K., Shin, D. B., Lee, J. H., & Lee, W. K. (2008). Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Quality of Life Research, 17(2), 207–214.PubMedCrossRef Park, S. H., Cho, M. S., Kim, Y. S., Hong, J., Nam, E., Park, J., Cho, E. K., Shin, D. B., Lee, J. H., & Lee, W. K. (2008). Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy. Quality of Life Research, 17(2), 207–214.PubMedCrossRef
20.
go back to reference Djarv, T., Metcalfe, C., Avery, K. N., Lagergren, P., & Blazeby, J. M. (2010). Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. Journal of Clinical Oncology, 28(10), 1666–1670.PubMedCrossRef Djarv, T., Metcalfe, C., Avery, K. N., Lagergren, P., & Blazeby, J. M. (2010). Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. Journal of Clinical Oncology, 28(10), 1666–1670.PubMedCrossRef
21.
go back to reference Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., Osoba, D., Bjordal, K., Bottomley, A., Groups EC. (2009). Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncology, 10(9), 865–871.PubMedCrossRef Quinten, C., Coens, C., Mauer, M., Comte, S., Sprangers, M. A., Cleeland, C., Osoba, D., Bjordal, K., Bottomley, A., Groups EC. (2009). Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncology, 10(9), 865–871.PubMedCrossRef
22.
go back to reference Ediebah, D. E., Quinten, C., Coens, C., Ringash, J., Dancey, J., Zikos, E., Gotay, C., Brundage, M., Tu, D., Flechtner, H. H., Greimel, E., Reeve, B. B., Taphoorn, M., Reijneveld, J., Dirven, L., Bottomley, A., Canadian Cancer Trials, G., the European Organization for, R., & Treatment of, C. (2018). Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from Canadian cancer trials group clinical trials. Cancer, 124(16), 3409–3416.PubMedCrossRef Ediebah, D. E., Quinten, C., Coens, C., Ringash, J., Dancey, J., Zikos, E., Gotay, C., Brundage, M., Tu, D., Flechtner, H. H., Greimel, E., Reeve, B. B., Taphoorn, M., Reijneveld, J., Dirven, L., Bottomley, A., Canadian Cancer Trials, G., the European Organization for, R., & Treatment of, C. (2018). Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from Canadian cancer trials group clinical trials. Cancer, 124(16), 3409–3416.PubMedCrossRef
23.
go back to reference Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.PubMedCrossRef Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.PubMedCrossRef
25.
go back to reference Fahmy, O., Fahmy, U. A., Alhakamy, N. A., & Khairul-Asri, M. G. (2021). Single-port versus multiple-port robot-assisted radical prostatectomy: A systematic review and meta-analysis. Journal of Clinical Medicine, 10(24), 5723.PubMedPubMedCentralCrossRef Fahmy, O., Fahmy, U. A., Alhakamy, N. A., & Khairul-Asri, M. G. (2021). Single-port versus multiple-port robot-assisted radical prostatectomy: A systematic review and meta-analysis. Journal of Clinical Medicine, 10(24), 5723.PubMedPubMedCentralCrossRef
26.
go back to reference Zhao, L., Song, Y., Dong, P., Li, Z., Yang, X., & Wang, S. (2014). Brachial pulse pressure and cardiovascular or all-cause mortality in the general population: A meta-analysis of prospective observational studies. Journal of Clinical Hypertension, 16(9), 678–685.PubMedPubMedCentralCrossRef Zhao, L., Song, Y., Dong, P., Li, Z., Yang, X., & Wang, S. (2014). Brachial pulse pressure and cardiovascular or all-cause mortality in the general population: A meta-analysis of prospective observational studies. Journal of Clinical Hypertension, 16(9), 678–685.PubMedPubMedCentralCrossRef
27.
go back to reference Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4), 1088–1101.PubMedCrossRef Begg, C. B., & Mazumdar, M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4), 1088–1101.PubMedCrossRef
28.
29.
go back to reference Hamers, P. A. H., Vink, G. R., Elferink, M. A. G., Stellato, R. K., Dijksterhuis, W. P. M., Punt, C. J. A., Koopman, M., May, A. M., group, Q. s. (2022). Quality of life and survival of metastatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS). Clinical Colorectal Cancer, 21(2), 154–166.PubMedCrossRef Hamers, P. A. H., Vink, G. R., Elferink, M. A. G., Stellato, R. K., Dijksterhuis, W. P. M., Punt, C. J. A., Koopman, M., May, A. M., group, Q. s. (2022). Quality of life and survival of metastatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS). Clinical Colorectal Cancer, 21(2), 154–166.PubMedCrossRef
30.
go back to reference Husson, O., de Rooij, B. H., Kieffer, J., Oerlemans, S., Mols, F., Aaronson, N. K., van der Graaf, W. T. A., & van de Poll-Franse, L. V. (2020). The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the “Real-World”: Results from the population-based profiles registry. The Oncologist, 25(4), e722–e732.PubMedCrossRef Husson, O., de Rooij, B. H., Kieffer, J., Oerlemans, S., Mols, F., Aaronson, N. K., van der Graaf, W. T. A., & van de Poll-Franse, L. V. (2020). The EORTC QLQ-C30 summary score as prognostic factor for survival of patients with cancer in the “Real-World”: Results from the population-based profiles registry. The Oncologist, 25(4), e722–e732.PubMedCrossRef
31.
go back to reference Fournier, E., Jooste, V., Woronoff, A. S., Quipourt, V., Bouvier, A. M., & Mercier, M. (2016). Health-related quality of life is a prognostic factor for survival in older patients after colorectal cancer diagnosis: A population-based study. Digestive and Liver Disease, 48(1), 87–93.PubMedCrossRef Fournier, E., Jooste, V., Woronoff, A. S., Quipourt, V., Bouvier, A. M., & Mercier, M. (2016). Health-related quality of life is a prognostic factor for survival in older patients after colorectal cancer diagnosis: A population-based study. Digestive and Liver Disease, 48(1), 87–93.PubMedCrossRef
32.
go back to reference Ratjen, I., Schafmayer, C., Enderle, J., di Giuseppe, R., Waniek, S., Koch, M., Burmeister, G., Nothlings, U., Hampe, J., Schlesinger, S., & Lieb, W. (2018). Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: A German cohort study. BMC Cancer, 18(1), 1156.PubMedPubMedCentralCrossRef Ratjen, I., Schafmayer, C., Enderle, J., di Giuseppe, R., Waniek, S., Koch, M., Burmeister, G., Nothlings, U., Hampe, J., Schlesinger, S., & Lieb, W. (2018). Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: A German cohort study. BMC Cancer, 18(1), 1156.PubMedPubMedCentralCrossRef
33.
go back to reference Frank, F., Hecht, M., Loy, F., Rutzner, S., Fietkau, R., & Distel, L. (2020). Differences in and prognostic value of quality of life data in rectal cancer patients with and without distant metastases. Healthcare (Basel), 9(1), 1.PubMedCrossRef Frank, F., Hecht, M., Loy, F., Rutzner, S., Fietkau, R., & Distel, L. (2020). Differences in and prognostic value of quality of life data in rectal cancer patients with and without distant metastases. Healthcare (Basel), 9(1), 1.PubMedCrossRef
34.
go back to reference Fitz, T., Sorgel, C., Rutzner, S., Hecht, M., Fietkau, R., & Distel, L. V. (2022). Baseline quality of life of physical function is highly relevant for overall survival in advanced rectal cancer. Healthcare (Basel), 10(1), 141.PubMedCrossRef Fitz, T., Sorgel, C., Rutzner, S., Hecht, M., Fietkau, R., & Distel, L. V. (2022). Baseline quality of life of physical function is highly relevant for overall survival in advanced rectal cancer. Healthcare (Basel), 10(1), 141.PubMedCrossRef
35.
go back to reference Djarv, T., & Lagergren, P. (2011). Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. European Journal of Cancer, 47(4), 530–535.PubMedCrossRef Djarv, T., & Lagergren, P. (2011). Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. European Journal of Cancer, 47(4), 530–535.PubMedCrossRef
36.
go back to reference Chang, Y. L., Tsai, Y. F., Chao, Y. K., & Wu, M. Y. (2016). Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer. Quality of Life Research, 25(2), 465–475.PubMedCrossRef Chang, Y. L., Tsai, Y. F., Chao, Y. K., & Wu, M. Y. (2016). Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer. Quality of Life Research, 25(2), 465–475.PubMedCrossRef
37.
go back to reference van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. H., Creemers, G. J., Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G., van Laarhoven, H. W. M., & Dutch Upper, G. I. C. G. (2021). Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: Analysis from the population-based POCOP study. Gastric Cancer, 24(6), 1203–1212.PubMedPubMedCentralCrossRef van Kleef, J. J., Dijksterhuis, W. P. M., van den Boorn, H. G., Prins, M., Verhoeven, R. H. A., Gisbertz, S. S., Slingerland, M., Mohammad, N. H., Creemers, G. J., Neelis, K. J., Heisterkamp, J., Rosman, C., Ruurda, J. P., Kouwenhoven, E. A., van de Poll-Franse, L. V., van Oijen, M. G. H., Sprangers, M. A. G., van Laarhoven, H. W. M., & Dutch Upper, G. I. C. G. (2021). Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: Analysis from the population-based POCOP study. Gastric Cancer, 24(6), 1203–1212.PubMedPubMedCentralCrossRef
38.
go back to reference van Amelsfoort, R. M., Walraven, I., Kieffer, J., Jansen, E. P. M., Cats, A., van Grieken, N. C. T., Meershoek-Klein Kranenbarg, E., Putter, H., van Sandick, J. W., Sikorska, K., van de Velde, C. J. H., Aaronson, N. K., Verheij, M., & Investigators, C. (2022). Quality of life is associated with survival in patients with gastric cancer: Results from the randomized CRITICS Trial. Journal of the National Comprehensive Cancer Network, 20(3), 261–267.PubMedCrossRef van Amelsfoort, R. M., Walraven, I., Kieffer, J., Jansen, E. P. M., Cats, A., van Grieken, N. C. T., Meershoek-Klein Kranenbarg, E., Putter, H., van Sandick, J. W., Sikorska, K., van de Velde, C. J. H., Aaronson, N. K., Verheij, M., & Investigators, C. (2022). Quality of life is associated with survival in patients with gastric cancer: Results from the randomized CRITICS Trial. Journal of the National Comprehensive Cancer Network, 20(3), 261–267.PubMedCrossRef
39.
go back to reference Mol, L., Ottevanger, P. B., Koopman, M., & Punt, C. J. (2016). The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients. European Journal of Cancer, 66, 138–143.PubMedCrossRef Mol, L., Ottevanger, P. B., Koopman, M., & Punt, C. J. (2016). The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients. European Journal of Cancer, 66, 138–143.PubMedCrossRef
40.
go back to reference Efficace, F., Collins, G. S., Cottone, F., Giesinger, J. M., Sommer, K., Anota, A., Schlussel, M. M., Fazi, P., & Vignetti, M. (2021). Patient-reported outcomes as independent prognostic factors for survival in oncology: Systematic review and meta-analysis. Value Health, 24(2), 250–267.PubMedCrossRef Efficace, F., Collins, G. S., Cottone, F., Giesinger, J. M., Sommer, K., Anota, A., Schlussel, M. M., Fazi, P., & Vignetti, M. (2021). Patient-reported outcomes as independent prognostic factors for survival in oncology: Systematic review and meta-analysis. Value Health, 24(2), 250–267.PubMedCrossRef
41.
go back to reference Nafteux, P., Durnez, J., Moons, J., Coosemans, W., Decker, G., Lerut, T., Van Veer, H., & De Leyn, P. (2013). Assessing the relationships between health-related quality of life and postoperative length of hospital stay after oesophagectomy for cancer of the oesophagus and the gastro-oesophageal junction. European Journal of Cardio-Thoracic Surgery, 44(3), 525–533. Discussion 533.PubMedCrossRef Nafteux, P., Durnez, J., Moons, J., Coosemans, W., Decker, G., Lerut, T., Van Veer, H., & De Leyn, P. (2013). Assessing the relationships between health-related quality of life and postoperative length of hospital stay after oesophagectomy for cancer of the oesophagus and the gastro-oesophageal junction. European Journal of Cardio-Thoracic Surgery, 44(3), 525–533. Discussion 533.PubMedCrossRef
42.
go back to reference Giesinger, J. M., Kieffer, J. M., Fayers, P. M., Groenvold, M., Petersen, M. A., Scott, N. W., Sprangers, M. A., Velikova, G., Aaronson, N. K., Group, E. Q. o. L. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88.PubMedCrossRef Giesinger, J. M., Kieffer, J. M., Fayers, P. M., Groenvold, M., Petersen, M. A., Scott, N. W., Sprangers, M. A., Velikova, G., Aaronson, N. K., Group, E. Q. o. L. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88.PubMedCrossRef
43.
go back to reference Cocks, K., Wells, J. R., Johnson, C., Schmidt, H., Koller, M., Oerlemans, S., Velikova, G., Pinto, M., Tomaszewski, K. A., Aaronson, N. K., Exall, E., Finbow, C., Fitzsimmons, D., Grant, L., Groenvold, M., Tolley, C., Wheelwright, S., Bottomley, A., European Organisation for, R., & Treatment of Cancer Quality of Life, G. (2023). Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. European Journal of Cancer, 178, 128–138.PubMedCrossRef Cocks, K., Wells, J. R., Johnson, C., Schmidt, H., Koller, M., Oerlemans, S., Velikova, G., Pinto, M., Tomaszewski, K. A., Aaronson, N. K., Exall, E., Finbow, C., Fitzsimmons, D., Grant, L., Groenvold, M., Tolley, C., Wheelwright, S., Bottomley, A., European Organisation for, R., & Treatment of Cancer Quality of Life, G. (2023). Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. European Journal of Cancer, 178, 128–138.PubMedCrossRef
44.
go back to reference Kumar, K., Mittal, A., Kamboj, D., Goel, G. S., Mittal, A., & Garg, S. K. (2023). Factors affecting quality of life of cancer patients in North India. Asian Pacific Journal of Cancer Prevention, 24(2), 641–648.PubMedPubMedCentralCrossRef Kumar, K., Mittal, A., Kamboj, D., Goel, G. S., Mittal, A., & Garg, S. K. (2023). Factors affecting quality of life of cancer patients in North India. Asian Pacific Journal of Cancer Prevention, 24(2), 641–648.PubMedPubMedCentralCrossRef
45.
go back to reference Park, S., Eo, W., & Lee, S. (2018). The relationship between health-related quality of life and survival in metastatic colorectal cancer patients treated with Korean medicine. Integrative Cancer Therapies, 17(1), 65–72.PubMedCrossRef Park, S., Eo, W., & Lee, S. (2018). The relationship between health-related quality of life and survival in metastatic colorectal cancer patients treated with Korean medicine. Integrative Cancer Therapies, 17(1), 65–72.PubMedCrossRef
46.
go back to reference Wong, C. K., Law, W. L., Wan, Y. F., Poon, J. T., & Lam, C. L. (2014). Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis. BMC Cancer, 14, 337.PubMedPubMedCentralCrossRef Wong, C. K., Law, W. L., Wan, Y. F., Poon, J. T., & Lam, C. L. (2014). Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis. BMC Cancer, 14, 337.PubMedPubMedCentralCrossRef
Metadata
Title
Baseline functioning scales of EORTC QLQ-C30 predict overall survival in patients with gastrointestinal cancer: a meta-analysis
Authors
Ye Zang
Yue Qiu
Yimeng Sun
Yu Fan
Publication date
16-01-2024
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 6/2024
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-023-03591-y

Other articles of this Issue 6/2024

Quality of Life Research 6/2024 Go to the issue